TITLE

TARO PHARMACEUTICALS ACQUIRES TIAMOL FOR U.S./CANADA

PUB. DATE
September 2000
SOURCE
Worldwide Biotech;Sep2000, Vol. 12. Issue 9, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports the market approval received by Tiamol, a dermatologic drug frok Taro Pharmaceutical Industries Inc., in the United States and Canada.
ACCESSION #
3533627

 

Related Articles

  • DRAXIS DIVESTS TIAMOL/KERASAL PRODUCT LINES TO TARO.  // Biotech Financial Reports;Aug2000, p3 

    Focuses on Ontario-based DRAXIS Health Inc.'s signing of an agreement to dispose of its Tiamol and Kerasal dermatological product lines to Taro Pharmaceuticals Industries Ltd. Value of the transaction; Completion of firm's divestiture of its dermatology marketing and selling operations.

  • Best Use of Direct Marketing to Healthcare Professionals.  // Medical Marketing & Media;Nov2004 Supplement, Vol. 39, p19 

    The article presents information about the creative idea by HeathInfo a division of HealthInfo Direct LLC in effective direct communications to healthcare professionals. Taro Pharmaceuticals Inc., which deals in head lice treatment, hired HealthInfo to develop a campaign to achieve 45 percent...

  • Taro Special Committee Rejects Proposal from Sun Pharma.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article informs that a proposal from Sun Pharmaceutical Industries Ltd. regarding purchase of shares has been rejected by Taro Pharmaceutical Industries Ltd. It further informs that Citigroup Global Markets Inc., an independent financial advisor has reviewed Taro's business and prospects...

  • Taro Special Committee Continues Its Evaluation of Sun Pharma's Proposal to Acquire Taro Shares.  // Biomedical Market Newsletter;1/14/2012, Vol. 21, p1 

    The article offers information on the evaluation of the nonbinding cash offered by Sun Pharmaceutical Industries Ltd to Taro Pharmaceutical Industries Ltd. It discusses the evaluation of the Taro shares to acquired which includes 24.50 dollar per share for all of theissued and outstanding shares...

  • FDA APPROVES TARO'S ANDA FOR KETOCONAZOLE CREAM.  // Biotech Business;Feb2003, Vol. 16 Issue 2, p4 

    Reports on the approval by the U.S. Food and Drug Administration of Taro Pharmaceutical Industries' abbreviated new drug application for Ketoconazole Cream, as of February 2003.

  • SWOT Analysis.  // Taro Pharmaceuticals Industries Ltd. SWOT Analysis;Nov2006, p5 

    A business analysis of Taro Pharmaceutical Industries Ltd., a multinational, pharmaceutical company, engaged in discovery, development, manufacturing and marketing of the highest quality healthcare products, is provided, focusing on its strengths, weaknesses, opportunities for improvement and...

  • SWOT Analysis.  // Taro Pharmaceuticals Industries Ltd. SWOT Analysis;Jun2007, p5 

    A business analysis of Taro Pharmaceutical Industries Ltd., which manufactures and markets prescription and over-the-counter pharmaceutical products, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include dominant market...

  • SWOT Analysis.  // Taro Pharmaceuticals Industries Ltd. SWOT Analysis;Aug2007, p5 

    A business analysis of Taro Pharmaceutical Industries Ltd., which develops, manufactures and markets prescription and over-the-counter (OTC) pharmaceutical products is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include...

  • Taro Pharmaceuticals Industries Ltd.  // Taro Pharmaceuticals Industries Ltd. SWOT Analysis;Sep2008, p1 

    A company profile of Taro Pharmaceutical Industries Ltd., a global pharmaceutical company engaged in the development, manufacturing and marketing of prescription and over-the-counter (OTC) pharmaceutical products, is presented. An overview of the company is given, along with key facts including...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics